Advancing New Healthcare Solutions Through Collaboration

Johnson & Johnson Innovation was thrilled to be back at HLTH 2021, coming together with leaders across the innovation ecosystem to explore the most promising opportunities to create health’s future. From helping to judge HLTH’s early-stage pitch competition, to hosting a private networking event with our partners, and holding 1-1 prospective partnering meetings with companies operating in our areas of interest, we are energized by the great scientists around us and glad to be part of this vibrant innovation community.

Innovators with transformative potential solutions to help or aim to advance precision medicine approaches in autoimmune disease are invited to apply for the chance to receive grant funding from a total of up to $500,000, access to the global JLABS network and mentorship from experts across the Johnson & Johnson Family of Companies.

Connecting with early innovators, entrepreneurs, and scientists to transform great ideas into life-changing solutions for people lies at Johnson & Johnson Innovation’s core. Elena Fernandez-Kleinlein, Regional Head of JLABS EMEA, explains how our global network enables collaboration to tackle some of the world’s most complex health challenges.

Johnson & Johnson Innovation is committed to working with the innovator community around the world with the aim to continue to accelerate potential transformational healthcare solutions during this unprecedented time.